Company intelligence / Profile preview

Atheln

San Diego, California, United Statesathelnbiomed.com ↗

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Atheln is a biopharma/biotech/medtech product development and commercial strategy consulting group. They provide customized, integrated solutions for clients at all stages of product development and commercialization. Their team of over 100 industry experts has experience from concept through regulatory approval and lifecycle management across diverse therapeutic areas.

Therapeutic areas: Rare DiseasesNeurologyPsychiatryDermatologyOphthalmologyGastroenterologyEndocrinologyHematologyOncologyMen's HealthNephrologyImmunology
Modalities: BiologicsMonoclonal antibodyAntibody-drug conjugateCell therapyGene therapyVaccineSmall molecule
Industry: Consulting

Partnerships

Works with numerous biopharma, biotech, medtech companies as clients

Beyond the preview

Go deeper on Atheln.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atheln.

Explore the full profile